EUVIMEDEUVIMED entdecken
Crossref

Chrysin ameliorates D-galactose-induced liver aging in mice: the impact of targeting Nrf2/AKT and CXCL1/TNF-α/P53 signaling pathways

Abeer Salama, Noha N Yassen, Samar S Khalaf, Mohamed I Fahmy iD

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgaf054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Abeer Salama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Department, National Research Centre, El-Buhouth St., Dokki, Cairo 12622, Egypt. Hauptthemen laut MEDLINE: Flavonoids, Galactose, Liver, Anti-Inflammatory Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Liver aging is a major cause of death all over the world. D-galactose (D-gal) induces liver aging via inflammatory pathways in Kupffer cells. Chrysin (CHR) is a flavonoid having anti-inflammatory and antioxidant effects that can protect liver from aging responses. This study aimed to clarify the hepatoprotective activity of CHR in D-gal-induced liver aging.

Methods

Four groups of male mice (10 mice each) were used in the study: normal control group, D-gal (200 mg/kg/day) group, D-gal group + 25 mg/kg/day CHR, and D-gal group + 50 mg/kg/day CHR. Treatment continued for 8 weeks. Key findings Elevation in cytochrome P2E1 (CYP2E1) enzyme, the chemokine (C-X-C motif) ligand-1 (CXCL-1), the cell surface adhesion receptor CD44, and tumor necrosis factor (TNF)-α occurred in D-gal group. Oxidative stress was evident through downregulation of catalase enzymes, nuclear factor erythroid 2-related factor 2 (Nrf2) and protein kinase B (AKT), and an increasing nitric oxide (NO) levels. Consequently, liver injury was evident with elevation of ALT and AST levels. These responses affected the morphology of the hepatic tissues. CHR managed to prevent these pathways and preserved normal morphology of the hepatic tissues.

Conclusions

Our study revealed that CHR prevents D-gal-induced liver aging through its anti-inflammatory and antioxidant effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsGalactoseLiverAnti-Inflammatory AgentsMaleAnimalsMiceNF-E2 Transcription FactorProto-Oncogene Proteins c-aktTumor Necrosis Factor-alphaNF-E2-Related Factor 2Oxidative StressChemokine CXCL1AntioxidantsAgingSignal Transduction

Stichwörter der Autor:innen

D-galactoseagingantioxidantchrysinliver

Substanzen

chrysinFlavonoidsGalactoseNF-E2 Transcription FactorProto-Oncogene Proteins c-aktTumor Necrosis Factor-alphaNfe2l2 protein, mouseNF-E2-Related Factor 2Chemokine CXCL1Antioxidants

Autor:innen und Institutionen

  • Pharmacology Department, National Research Centre, El-Buhouth St., Dokki, Cairo 12622, Egypt.
  • Pathology Department, National Research Centre, El-Buhouth St., Dokki, Cairo 12622, Egypt.
  • Biochemistry Department, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt.
  • Department of Pharmacology and Toxicology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), P.O. Box 77, Giza 12585, Egypt.

ORCID-Profile: Mohamed I Fahmy

Zitieren

APA

Salama, A., Yassen, N. N., Khalaf, S. S., & Fahmy, M. I. (2025). Chrysin ameliorates D-galactose-induced liver aging in mice: the impact of targeting Nrf2/AKT and CXCL1/TNF-α/P53 signaling pathways. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf054

Vancouver

Salama A, Yassen NN, Khalaf SS, Fahmy MI. Chrysin ameliorates D-galactose-induced liver aging in mice: the impact of targeting Nrf2/AKT and CXCL1/TNF-α/P53 signaling pathways. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf054

BibTeX
@article{Salama2025,
  author = {Salama, Abeer and Yassen, Noha N and Khalaf, Samar S and Fahmy, Mohamed I},
  title = {Chrysin ameliorates D-galactose-induced liver aging in mice: the impact of targeting Nrf2/AKT and CXCL1/TNF-α/P53 signaling pathways},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgaf054}
}
Kostenlos starten →